This study provides a comprehensive analysis of cancer-related place of death (PoD) in 12 Latin American countries, highlighting significant cross-country variations and identifying key factors associated with dying at home versus in a hospital.

Endoplasmic reticulum stress response is a deterministic factor defining the death in cancer cells treated with a combination of artemisinins and TRAIL.

Weight gain is a common side effect of breast cancer treatment and is associated with increased cancer progression and mortality. GLP-1 receptor agonists are emerging as potential weight loss therapies for patients with breast cancer. There are key questions central to this paper: Are GLP-1 agents safe? Do they promote weight loss, and do they improve breast cancer outcomes?.

Our study highlights the innovative discovery that miRNAlet-7b-5p targets the IGF1R and inhibits the AKT/mTOR pathway, which has significant implications in the development of novel therapies to combat HCC, including qRT-PCR, clone formation assays, EdU experiments, scratch healing experiments, Transwell experiments, PI experiments, and protein immunoblotting.